SCHEMBL13048816

SCHEMBL13048816

COC(=O)c1ccc(-c2cccc(Nc3nc(NC4CC4)c4c(S(C)(=O)=O)n[nH]c4n3)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.39
BRD2 P25440 2/20 0.39
SYK P43405 9/20 0.39
USP2 O75604 3/20 0.39
CYP1A2 P05177 3/20 0.39
CLK4 Q9HAZ1 3/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C19 P33261 2/20 0.39
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39
CSNK2A1 P68400 1/20 0.38
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
ITGB3 P05106 1/20 0.37
ITGAV P06756 1/20 0.37
CLK1 P49759 1/20 0.37
CLK2 P49760 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13048825 0.92 PIK3CG (0.45) SYKUSP2CYP1A2CLK4CYP3A4
SCHEMBL13048813 0.92 SYK (0.44) SYK
SCHEMBL13048799 0.84 SYK (0.44) SYKUSP2CYP1A2CLK4CYP3A4
SCHEMBL13048811 0.84 SYK (0.44) SYKUSP2CYP1A2CLK4CYP3A4
SCHEMBL13048821 0.83 MERTK (0.48) SYKCSNK2A1MERTK
SCHEMBL13048648 0.82 PIK3CD (0.43) SYKCSNK2A1PIK3CDPIK3CAPIK3CB
SCHEMBL13048641 0.81 SYK (0.45) SYKMAPK1CSNK2A1PIK3CDPIK3CA
SCHEMBL13048627 0.81 PIK3CD (0.41) SYKCSNK2A1PIK3CDPIK3CAPIK3CB
SCHEMBL13048827 0.80 SYK (0.43) SYKCLK4MAPK1CSNK2A1CLK2
SCHEMBL13048603 0.79 SYK (0.48) SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298557-A1 PYRAZOLOPYRIMIDINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2010-11-25 US disclosed
US-20100298557-A1 PYRAZOLOPYRIMIDINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298557-A1 PYRAZOLOPYRIMIDINE COMPOUND SYK, LCK, FYN BRD4 1757/4885BRD2 2625/4885SYK 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.